» Authors » Torben Steiniche

Torben Steiniche

Explore the profile of Torben Steiniche including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 142
Citations 1775
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Andersen K, Salachan P, Borre M, Ulhoi B, Stougaard M, Sorensen K, et al.
Infect Agent Cancer . 2024 Nov; 19(1):57. PMID: 39543738
Background: Human papillomavirus (HPV) has been proposed to contribute to the carcinogenesis of prostate cancer. However, previous studies have yielded conflicting results. This study aims to add useful information to...
2.
Bonlokke S, Stougaard M, Blaakaer J, Bertelsen J, Andersen K, Fuglsang K, et al.
Pathol Res Pract . 2024 Nov; 264:155672. PMID: 39520972
Introduction: High-risk human papillomavirus (HPV) has been detected in distant metastases from cervical cancer (CC) patients, suggesting a role of HPV. Material And Methods: Here, we included 26 patients with...
3.
Danielsen M, Emmanuel T, Nielsen M, Lindahl L, Gluud M, Odum N, et al.
Front Oncol . 2024 Oct; 14:1421443. PMID: 39435287
Introduction: The majority of patients with mycosis fungoides (MF) have an indolent disease course, but a substantial fraction (20-30%) of patients progress to advanced stages - usually with a grave...
4.
Greisen S, Bendix M, Nielsen M, Pedersen K, Jensen N, Hvid M, et al.
J Immunother Cancer . 2024 Oct; 12(10). PMID: 39357979
Introduction: Immune checkpoint inhibitors (ICI) have revolutionized the treatment of metastatic malignant melanoma (MM) and improved long-term survival. Despite the impressive results, some patients still have progressive disease, and the...
5.
Enevoldsen J, Brogard M, Lade-Keller J, Bang Christensen K, Georgsen J, Nielsen P, et al.
Pathol Res Pract . 2024 Aug; 262:155543. PMID: 39154604
Aims: In this proof-of-concept study, we propose a new method for automated digital quantification of PRAME (PReferentially expressed Antigen of MElanoma) as a diagnostic aid to distinguish between benign and...
6.
Emmanuel T, Ignatov B, Bertelsen T, Litman T, Nielsen M, Brent M, et al.
Int J Mol Sci . 2024 Jun; 25(11). PMID: 38892277
Secukinumab and Dead Sea treatment result in clear skin for many psoriasis patients, through distinct mechanisms. However, recurrence in the same areas after treatments suggests the existence of a molecular...
7.
Ringgaard M, Steiniche T, Krag S
APMIS . 2024 Jun; 132(9):632-637. PMID: 38873700
Fifteen percent of all colorectal cancers have detectable defects in the mismatch repair system (dMMR). MMR status is used to identify possible Lynch Syndrome (LS) and to determine prognosis and...
8.
Bonlokke S, Blaakaer J, Steiniche T, Iachina M
BMC Cancer . 2024 Feb; 24(1):259. PMID: 38395802
Background: For cervical cancer (CC), the implementation of preventive strategies has the potential to make cervical cancer occurrence and death largely avoidable. To better understand the factors possibly responsible for...
9.
Damgaard R, Jenkins D, Stoler M, de Koning M, van de Sandt M, Lycke K, et al.
Am J Obstet Gynecol . 2024 Feb; 230(6):655.e1-655.e10. PMID: 38336125
Background: In recent years, active surveillance has been introduced as an alternative to excisional treatment in younger women with cervical intraepithelial neoplasia grade 2 because regression rates are high and...
10.
Brogard M, Nielsen P, Bang Christensen K, Georgsen J, Wandler A, Lade-Keller J, et al.
Pathol Res Pract . 2024 Feb; 255:155177. PMID: 38330618
Aims: Pathologists often use immunohistochemical staining of the proliferation marker Ki67 in their diagnostic assessment of melanocytic lesions. However, the interpretation of Ki67 can be challenging. We propose a new...